Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vitamin A for prevention of retinopathy of prematurity in low birth weight neonates
IRCT20120215009014N403Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vitamin a in retinopathy of prematurity (ROP) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Incidence of retinopathy of prematurity. Started Aug 2021; status: completed.
02
Drugs
vitamin a
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on IRCT20120215009014N403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N403.